Company Analysis
Sign in

Twist Bioscience Corporation (TWST)

Nasdaq: TWST · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2013
Full chart Alerts Compare
Grade6.2
◀ Past 7.2● Present 7.6▶ Future 4.4
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

66 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Twist Bioscience Corporation’s names, not what it holds today.

Patents granted
66
66 utility, 1976 to Dec 31, 2025
Granted in 2025
9
Against 6 in 2024 and 8 in 2023
Applications published
148
11 of them in 2025
Names they are printed under
5
its own name, a subsidiary
By yearGrantedApplications published
'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology23
Computer technology6
Chemical engineering4
Organic fine chemistry4
Pharmaceuticals3
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Twist Bioscience Corporation its own name
named as the applicant on its applications, in US
0 granted
130 published
Twist Bioscience Corporation its own name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in CA)
64 granted
11 published
iGenomX International Genomics Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
iGenomX International Genomics Corporation a subsidiary
US, as the owner printed on each patent
2 granted
1 published
GENOME COMPILER CORPORATION a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 19, 202512,391,762Methods and compositions relating to GLP1R variantsPharmaceuticalsTwist Bioscience Corporation
Jul 15, 202512,357,959Highly accurate de novo polynucleotide synthesisOrganic fine chemistryTwist Bioscience Corporation
Jun 17, 202512,331,427Antibodies that bind GLP1RBiotechnologyTwist Bioscience Corporation
Jun 10, 202512,325,739Bispecific SARS-CoV-2 antibodies and methods of usePharmaceuticalsTwist Bioscience Corporation
May 20, 202512,304,965Variant nucleic acid libraries for coronavirusBiotechnologyTwist Bioscience Corporation
Apr 8, 202512,270,028Methods for seamless nucleic acid assemblyBiotechnologyTwist Bioscience Corporation
Mar 25, 202512,258,406Antibodies that bind CD3 EpsilonBiotechnologyTwist Bioscience Corporation
Jan 21, 202512,202,905Methods and compositions relating to adenosine receptorsBiotechnologyTwist Bioscience Corporation
Jan 21, 202512,201,857Methods and compositions relating to covid antibody epitopesPharmaceuticalsTwist Bioscience Corporation
Dec 24, 202412,173,282Antibodies that bind CD3 epsilonBiotechnologyTwist Bioscience Corporation
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 4, 20252025/0369027SUBSTRATE CLEAVAGE FOR NUCLEIC ACID SYNTHESISBiotechnologyTwist Bioscience Corporation
Nov 20, 20252025/0352972HIGHLY ACCURATE DE NOVO POLYNUCLEOTIDE SYNTHESISOrganic fine chemistryTwist Bioscience Corporation
Nov 6, 20252025/0340658Methods and Compositions Relating to GLP1R VariantsPharmaceuticalsTwist Bioscience Corporation
Oct 30, 20252025/0335346CODECS FOR DNA DATA STORAGEComputer technologyTwist Bioscience Corporation
Aug 28, 20252025/0270737Antibodies That Bind GLP1RBiotechnologyTwist Bioscience Corporation
Jun 12, 20252025/0188445LIBRARIES FOR NEXT GENERATION SEQUENCINGBiotechnologyTwist Bioscience Corporation
May 15, 20252025/0154589FLEXIBLE SUBSTRATES FOR NUCLEIC ACID SYNTHESISBiotechnologyTwist Bioscience Corporation
May 15, 20252025/0154502METHODS FOR SEAMLESS NUCLEIC ACID ASSEMBLYBiotechnologyTwist Bioscience Corporation
May 8, 20252025/0145987Antibodies that Bind CD3 EpsilonBiotechnologyTwist Bioscience Corporation
May 8, 20252025/0145724Methods and Compositions Relating to Adenosine ReceptorsBiotechnologyTwist Bioscience Corporation
What it applied for, 2024 to 2025: Biotechnology 11 · Organic fine chemistry 2 · Computer technology 2 · Chemical engineering 1 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TWST · research, not advice